General MedicationsORALStandard

ATAZANAVIR SULFATE

Standard Dose

EQ 300MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview ATAZANAVIR SULFATE is listed in Drugs@FDA under application 212579 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ATAZANAVIR SULFATE Form and strength CAPSULE;ORAL - EQ 300MG BASE Sponsor LAURUS Submission history Latest submission status date: 2024-06-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview ATAZANAVIR SULFATE is listed in Drugs@FDA under application 212579 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ATAZANAVIR SULFATE Form and strength CAPSULE;ORAL - EQ 300MG BASE Sponsor LAURUS Submission history Latest submission status date: 2024-06-21 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.